A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)

This study has been completed.

Study NCT00258063 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: November 22, 2005 Last Updated: June 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given